Get the Ricochet app
Ricochet will work fine in a browser on your mobile devices, but for the best experience please download our app.

3 Whisky Happy Hour
The Ricochet Podcast
GLoP Culture
Beyond the Polls with Henry Olsen
Parsing Immigration Policy
Federalist Radio Hour
What the Hell Is Going On
Freedom to Learn
Daily Signal
The Erick Erickson Show
Chicks on The Right
3 Martini Lunch
The Learning Curve
The Conservative Woman’s Guide
Heritage Explains
Not Dead Yet
Giving Ventures
Who Funds that?
The Radio Free Hillsdale Hour
The Glenn Show
Call Me Back - with Dan Senor
Hillsdale Dialogues
Law Talk with Epstein, Yoo & Cooke
The Libertarian
The Report Card with Nat Malkus
The Kevin Roberts Show with Larry O’Connor
The American Idea
Madison’s Notes
Conservative Crossroads with Henry Olsen
Mom Wars
The Back of the Book
Gray Matters
Martini Shot
The Dave Carter Show
The Powerline Show
In Dissent
Heard at Heritage
Smart Girl Politics
James Lileks’ The Diner
Case in Point: The Legal Show on the Hottest Legal Cases in Politics and Culture
JobMakers
One on One with Robert Doar
Homeschooling Journeys with Curious MikeRicochet will work fine in a browser on your mobile devices, but for the best experience please download our app.
Tired of the toxicity of social media? Why not join Ricochet for just $5/month? Think of it as an online bar. Come in, have a drink, hang out, say whatever you want. But don’t badger, bully, or berate the other drinkers. That's our only rule.
Join host Joe Selvaggi and Pioneer’s Bill Smith in a conversation with Hannah Mamuszka, expert in diagnostic medicine, on why the U.S. lacked adequate early testing, what current testing looks like in the Commonwealth, and where testing technology needs to be to support public gatherings in the future.
Hannah Mamuszka is Founder & CEO of ALVA10, a healthcare technology firm. Hannah has spent her 20+ year career in diagnostics - both in pharma and at diagnostics companies, in the lab and on the business side. She believes that the challenges of diagnostic technology fully impacting patient care are more commercial than technical, and conceived of ALVA10 to create a mechanism to pull technology into healthcare by aligning incentives through data. She regularly speaks on issues regarding advancement of technology in healthcare, is on the Board of Directors for two diagnostic companies and writes a column on the value of diagnostics for the Journal of Precision Medicine.